AgNovos Bioscience: Funding, Investors & Team (Sep 2026)
AgNovos Bioscience develops new medical technology products leveraging regenerative medicine to address the local effects of bone disease. The company has conducted extensive pre-clinical and clinical research on its first treatment, OSSURE™ LOEP (Local Osteo-Enhancement Procedure).
AgNovos Bioscience has raised $31.5M across 1 funding round on record, the most recent an undisclosed round of $31.5M announced in Jun 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AgNovos Bioscience Company Profile and Key Stats
Latest funding round on record: Jun 2023.
AgNovos Bioscience Funding Rounds
AgNovos Bioscience Founders and Leadership Team
Contact details for the AgNovos Bioscience team: 1 of 1 has an email address on file.
Start 14-day free trial →AgNovos Bioscience Funding Compared to Other Biotechnology Startups
AgNovos Bioscience's latest round of $31.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AgNovos Bioscience in Biotechnology and Rockville
Companies Similar to AgNovos Bioscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
AgNovos Bioscience Funding FAQs
What does AgNovos Bioscience do?
AgNovos Bioscience develops new medical technology products leveraging regenerative medicine to address the local effects of bone disease. The company has conducted extensive pre-clinical and clinical research on its first treatment, OSSURE™ LOEP (Local Osteo-Enhancement Procedure).
How much funding has AgNovos Bioscience raised?
AgNovos Bioscience has raised $31.5M across 1 round on record. The most recent is an undisclosed round of $31.5M announced in Jun 2023.
When did AgNovos Bioscience last raise funding?
AgNovos Bioscience's most recent funding round on record is an undisclosed round of $31.5M, announced in Jun 2023.
Who founded AgNovos Bioscience?
FundedIQ lists James Howe (Founder) at AgNovos Bioscience.
Where is AgNovos Bioscience headquartered?
AgNovos Bioscience is based in Rockville, Maryland, United States.
How many employees does AgNovos Bioscience have?
AgNovos Bioscience is in the 51-100 employee band.
How does AgNovos Bioscience's funding compare to other Biotechnology startups?
AgNovos Bioscience's latest round of $31.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's AgNovos Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AgNovos Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.